Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.aspiradiagnostics.com | |
Market Cap | 42.61 Cr. | |
Enterprise Value(EV) | 39.75 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.98 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 20.86 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 47.03 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 12.16 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 3.40 | Calculated using Price: 41.40 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.03 Cr. | 10,293,000 Shares |
FaceValue | 10 | |
Company Profile | ||
The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. |
1 Day |
|
-2.93% |
1 Week |
|
-2.70% |
1 Month |
|
+3.11% |
3 Month |
|
-8.51% |
6 Month |
|
-19.38% |
1 Year |
|
-54.05% |
2 Year |
|
+54.77% |
5 Year |
|
|
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.55 | 1.10 | 0.76 | -57.04 | -178.61 | -187.57 | -94.32 | 22.80 | 42.26 | |
Return on Capital Employed (%) | 3.88 | 3.95 | 1.78 | -25.35 | -38.38 | -34.50 | -26.30 | 21.52 | 41.63 | |
Return on Assets (%) | 2.55 | 1.05 | 0.54 | -25.76 | -40.76 | -37.93 | -29.11 | 10.58 | 29.82 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 1 | 4 | 4 | 6 | 0 | 5 | 4 | 8 | 13 | 13 | |
Non Curr. Liab. | 3 | 11 | 5 | 5 | 1 | 4 | 3 | ||||
Curr. Liab. | 0 | 3 | 6 | 2 | 4 | 5 | 2 | 2 | 2 | ||
Minority Int. | |||||||||||
Equity & Liab. | 1 | 4 | 6 | 15 | 13 | 15 | 14 | 12 | 18 | 18 | |
Non Curr. Assets | 1 | 11 | 11 | 13 | 11 | 8 | 11 | 10 | |||
Curr. Assets | 1 | 4 | 6 | 4 | 2 | 2 | 3 | 4 | 7 | 7 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1 | 4 | 6 | 15 | 13 | 15 | 14 | 12 | 18 | 18 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 1 | 4 | 8 | 8 | 15 | 20 | 17 | ||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 0 | 0 | 0 | 1 | 5 | 8 | 9 | 15 | 20 | 17 | |
Total Expenditure | 0 | 0 | 0 | -3 | -8 | -11 | -10 | -12 | -13 | -13 | |
PBIDT | 0 | 0 | 0 | -2 | -4 | -3 | -2 | 4 | 6 | 4 | |
Interest | 0 | 0 | 0 | -1 | -1 | -1 | -1 | 0 | 0 | ||
Depreciation | 0 | -1 | -1 | -2 | -1 | -2 | -2 | ||||
Taxation | 0 | 0 | 0 | 0 | |||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | -3 | -6 | -5 | -4 | 1 | 4 | 2 | |
Adjusted EPS | 0 | 0 | 0 | -5 | -11 | -6 | -5 | 1 | 4 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | -5 | -3 | -2 | 6 | 2 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | -10 | -1 | -2 | 0 | 0 | -1 | |
Cash Fr. Finan. | 3 | 3 | 9 | 7 | 3 | 1 | -2 | -1 | |||
Net Change | 0 | 0 | 3 | 2 | -3 | 1 | -2 | 0 | 3 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 3 | 5 | 3 | 0 | -2 | -2 | 1 | 1 |
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2022 as received from Link Intime India Pvt. Ltd the Registrar and Share Transfer Agent (RTA) of the Company. |
Mon, 02 Jan 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali Nikunj Velji Mange Shraddha Bhanushali & Raj Arvind Bhanushali |
Sat, 31 Dec 2022
Closure of Trading Window Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the code of Prohibition of Insider Trading adopted by Company the trading window for dealing in securities of the company will remain closed from January 01 2023 till 48 hours after declaration of Financial Results of the Company for the quarter ended December 31 2022. |
Fri, 27 Jan 2023 |
|
|
|
|
|